Send me a link:

*Text messaging rates may apply.

 Dow Up0.36% Nasdaq Up0.71%

Intercept Pharmaceuticals, Inc. (ICPT)

-NasdaqGS
223.00 Jul 22, 3:59PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 405   405   405   405  
Cost of Revenue -   -   -   -  
Gross Profit 405   405   405   405  
Operating Expenses
Research Development25,930  9,583  8,393  5,133  
Selling General and Administrative5,651  4,729  3,115  2,891  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (31,175) (13,907) (11,102) (7,618)
Income from Continuing Operations
Total Other Income/Expenses Net(226,490)1,539  (20,635)(5,859)
Earnings Before Interest And Taxes(257,666)(12,368)(31,737)(13,477)
Interest Expense -   -   -   -  
Income Before Tax(257,666)(12,368)(31,737)(13,477)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(257,666)(12,368)(31,737)(13,477)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (257,666) (12,368) (31,737) (13,477)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (257,666) (12,368) (31,737) (13,477)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.